Showing results (801-810 of 933) with videos related to
Sort By:
Pageof 94
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 12, 2008
Correlation of functional impairment and morphological alterations in patients with group 2A idiopathic juxtafoveal retinal telangiectasiaSteffen Schmitz-Valckenberg, Kristie Fan, Alex Nugent, et al.The Journal of Biological Chemistry|January 22, 2015
Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairsJacomijn P Dijksterhuis, Bolormaa Baljinnyam, Karen Stanger, et al.Science (New York, N.Y.)|February 15, 1991
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene productD P Bottaro, J S Rubin, D L Faletto, et al.Current Opinion in Ophthalmology|November 5, 1991
Visual prostheses and visual rehabilitation in low vision research, assessment, and managementD Finkelstein, S J Feinberg, R E Flom, et al.Advances in Therapy|November 29, 2018
IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 StudyChristina Marciniak, Michael C Munin, Allison Brashear, et al.Neurology|July 9, 2003
Inflammatory markers and cognition in well-functioning African-American and white eldersK Yaffe, K Lindquist, B W Penninx, et al.BJA Open|December 11, 2025
Determining reduced functional capacity in older adults using research-grade wearable accelerometers: a secondary analysis of the study of muscle, mobility, and agingAnthony Hung, Nancy W Glynn, Reagan E Garcia, et al.The Journal of Biological Chemistry|May 31, 1996
Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activityV Cioce, K G Csaky, A M Chan, et al.Structure (London, England : 1993)|March 11, 1998
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding siteH Zhou, M J Mazzulla, J D Kaufman, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptorM F Mullarkey, K M Leiferman, M S Peters, et al.Pageof 94